Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038985 · ClinicalTrials.gov registry record · NA
Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis
A NA study, sponsored by AdventHealth.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02038985 is a NA study that was terminated before completion, run by AdventHealth. The registered enrollment target is 18 participants.
The verdict
NCT02038985, a NA study, was terminated before completion, sponsored by AdventHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of fluorescence imaging + Indocyanine Green (ICG) dye ("Firefly"), compared to standard white light imaging in 2D and 3D, for accurate visual diagnosis of endometriosis during a da Vinci robotically guided endometriosis resection procedure.
Interventions
- OTHER Participants will receive ICG Dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02038985
The ClinicalTrials.gov registry entry for NCT02038985 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Participants will receive ICG Dye is the first listed.
NCT02038985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02038985 about?
NCT02038985 is a clinical study titled "Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis". The purpose of this study is to evaluate the use of fluorescence imaging + Indocyanine Green (ICG) dye ("Firefly"), compared to standard white light imaging in 2D and 3D, for accurate visual diagnosis of endometriosis during a da Vinci robotically guided endometriosis resection procedure.
What is the current status of trial NCT02038985?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2013-06. Estimated completion is 2016-08-16.
What interventions are being tested in trial NCT02038985?
The interventions under investigation include: Participants will receive ICG Dye (OTHER).
Who is sponsoring clinical trial NCT02038985?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.